The new 2024 Progress Report assesses the same eleven countries as the 2021 Index: Brazil, Canada, China, France, Germany, India, Italy, Japan, South Korea, the United Kingdom (UK), and the United States (US). The 2021 Index examined over 100 metrics to evaluate and rank countries’ performance against AMR and establish benchmarks for policy action and leadership.

Across indicators, the 2024 Progress Report found that more needs to be done to put a firm halt to the spread of AMR, including the following points:

• Governments should invest further in national action plans, making bold investments in AMR countermeasures as a key element of health system resiliency.
• Governments should implement robust push and pull incentives to revitalize antibiotic innovation.
• Governments should make the availability of novel antimicrobials a national priority, ensuring access and affordability.
• Governments should invest further in infectious disease training for medical professionals and better incentivize specialization in infectious disease medicine.
• Governments should work to further strengthen and connect resistance and antimicrobial consumption surveillance systems, including by investing in diagnostics infrastructure.
• Governments should further support data collection on AMR in the environment.

Both the AMR Preparedness Index and the 2024 Progress Report were created in partnership with the Infectious Diseases Society of America and supported by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).